Review
doi: 10.2174/1568011054866928.
An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein-inhibitor complexes
Affiliations
- PMID: 16178778
- DOI: 10.2174/1568011054866928
Item in Clipboard
Review
An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein-inhibitor complexes
Curr Med Chem Anticancer Agents.
2005 Sep.
Abstract
CDK2 is an attractive target for the design of new therapeutic antitumor agent. Numerous CDK2 inhibitors have been discovered and their crystallographic structures either in complex with CDK2 or CDK2/Cyclin A have been published. This review aims to summarize the publicly available structural characterization of CDK2/(Cyclin A) -- ligand complexes and to highlight the similarities among the binding modes of structurally diverse inhibitors.
Similar articles
-
Analysis of CDK2 active-site hydration: a method to design new inhibitors.Proteins. 2004 May 1;55(2):258-74. doi: 10.1002/prot.20026. Proteins. 2004. PMID: 15048820
-
Alternative binding modes of an inhibitor to two different kinases.Eur J Biochem. 2003 Aug;270(15):3174-81. doi: 10.1046/j.1432-1033.2003.03697.x. Eur J Biochem. 2003. PMID: 12869192
-
Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine.Proteins. 1995 Aug;22(4):378-91. doi: 10.1002/prot.340220408. Proteins. 1995. PMID: 7479711
-
X-ray crystallographic studies of CDK2, a basis for cyclin-dependent kinase inhibitor design in anti-cancer drug research.Curr Med Chem Anticancer Agents. 2003 Jan;3(1):15-23. doi: 10.2174/1568011033353515. Curr Med Chem Anticancer Agents. 2003. PMID: 12678911 Review.
-
Chemical inhibitors of cyclin-dependent kinases: insights into design from X-ray crystallographic studies.Pharmacol Ther. 1999 May-Jun;82(2-3):269-78. doi: 10.1016/s0163-7258(98)00051-5. Pharmacol Ther. 1999. PMID: 10454204 Review.
Cited by
-
Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma.J Enzyme Inhib Med Chem. 2022 Dec;37(1):686-700. doi: 10.1080/14756366.2022.2036985. J Enzyme Inhib Med Chem. 2022. PMID: 35139719 Free PMC article.
-
Visualization of macromolecular structures.Nat Methods. 2010 Mar;7(3 Suppl):S42-55. doi: 10.1038/nmeth.1427. Epub 2010 Mar 1. Nat Methods. 2010. PMID: 20195256 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources